This inventor holds 1 USPTO granted patent. Top assignee: Pharmuka Laboratoires. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Innovations of Jean-Claude Bondiou in Medicinal Chemistry
Introduction
Jean-Claude Bondiou is a prominent inventor based in Montrouge, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative approach to the preparation of quinuclidine derivatives. With a focus on improving chemical processes, Bondiou's work has the potential to enhance the development of new medications.
Latest Patents
Bondiou holds a patent for a process that streamlines the preparation of derivatives of quinuclidine. The patent details a method involving the reaction of 3-methylene quinuclidine with aluminum hydride in a suitable solvent, coupled with a catalytic quantity of a transition metal halide. The molar ratio of the reagents is critical, being at least equal to 0.6. This innovative process allows for the in situ reaction of the resulting product with an ester, followed by further reactions with electrophilic reactants that yield various functional groups. The compounds produced via this method hold promise for use in the preparation of medicaments.
Career Highlights
Jean-Claude Bondiou is associated with Pharmuka Laboratoires, where he applies his expertise in medicinal chemistry to drive innovation. His patent illustrates his commitment to enhancing drug development processes, making him a valuable asset to the research community. Through his inventive contributions, he plays a vital role in advancing pharmaceutical science.
Collaborations
Throughout his career, Bondiou has collaborated with notable colleagues such as Francoise Hodac and Didier Legroux. These partnerships emphasize the importance of teamwork in scientific research and innovation, leading to the successful development of new chemical processes and compounds.
Conclusion
Jean-Claude Bondiou's contributions to the field of medicinal chemistry, particularly through his patented process for synthesizing quinuclidine derivatives, mark an important advancement in pharmaceutical development. His collaborations at Pharmuka Laboratoires further enhance his ability to innovate and push the boundaries of chemical research, ultimately benefiting the creation of effective medicaments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile